ReWalk Robotics Ltd. (LFWD)
Automate Your Wheel Strategy on LFWD
With Tiblio's Option Bot, you can configure your own wheel strategy including LFWD - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol LFWD
- Rev/Share 0.4233
- Book/Share -0.0214
- PB 2.4416
- Debt/Equity 0.0335
- CurrentRatio 0.0
- ROIC 1.8319
- MktCap 8707526.0
- FreeCF/Share -0.3255
- PFCF -0.4456
- PE -1.9908
- Debt/Assets 0.0
- DivYield 0
- ROE -0.8393
- Rating C-
- Score 1
- Recommendation Strong Sell
- P/E Score 1
- DCF Score 1
- P/B Score 2
- D/E Score 3
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Initiation | LFWD | Laidlaw | -- | Buy | -- | $10 | Feb. 10, 2025 |
News
MedRhythms Appoints Larry Jasinski as Chief Executive Officer to Lead Next Phase of Growth and Commercial Expansion
Published: July 07, 2025 by: PRNewsWire
Sentiment: Neutral
Industry veteran with proven track record in neurorehabilitation and fundraising to lead next phase of growth; Co-founder Brian Harris transitions to Chief Scientific Officer PORTLAND, Maine , July 7, 2025 /PRNewswire/ -- MedRhythms, Inc., a company pioneering the development of next-generation neurotherapeutics to improve walking, mobility and related functional outcomes, and creator of the world's first prescription music platform, announced the appointment of Larry Jasinski as Chief Executive Officer, effective immediately. Co-founder of MedRhythms, Brian Harris, who led the company through product development, successful clinical trials, listing product with the Food and Drug Administration (FDA), and assignment by the Centers …
Read More
Lifeward Announces Pricing of $2.6 Million Public Offering
Published: June 25, 2025 by: GlobeNewsWire
Sentiment: Neutral
MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, June 25, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd. (NASDAQ: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology to transform the lives of people with physical limitations or disabilities, today announced the pricing of a public offering of an aggregate of 4,000,000 of the Company's ordinary shares and accompanying warrants to purchase up to 4,000,000 of the Company's ordinary shares, at a combined public offering price of $0.65 per ordinary share and associated ordinary warrant. The ordinary warrants will have an exercise price of $0.65 per ordinary share, will be exercisable …
Read More
Lifeward Names Mark Grant as New CEO
Published: May 19, 2025 by: GlobeNewsWire
Sentiment: Neutral
MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, May 19, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd.
Read More
Lifeward to Present at Sidoti Virtual Investor Conference on May 21
Published: May 19, 2025 by: GlobeNewsWire
Sentiment: Neutral
MARLBOROUGH, Mass., and YOKNEAM ILLIT, Israel, May 19, 2025 (GLOBE NEWSWIRE) -- Lifeward, Ltd.
Read More
Lifeward (LFWD) Reports Q1 Loss, Lags Revenue Estimates
Published: May 15, 2025 by: Zacks Investment Research
Sentiment: Negative
Lifeward (LFWD) came out with a quarterly loss of $0.46 per share versus the Zacks Consensus Estimate of a loss of $0.33. This compares to loss of $0.73 per share a year ago.
Read More
Lifeward Ltd. (LFWD) Q1 2025 Earnings Call Transcript
Published: May 15, 2025 by: Seeking Alpha
Sentiment: Neutral
Lifeward Ltd. (NASDAQ:LFWD ) Q1 2025 - Earnings Conference Call May 15, 2025 8:30 AM ET Company Participants Mike Lawless - CFO Larry Jasinski - CEO Almog Adar - VP, Finance Conference Call Participants Yale Jen - Laidlaw and Company Swayampakula Ramakanth - H.
Read More
Lifeward Completes Research Program with Israeli Human-Robot Interaction Consortium to Integrate Artificial Intelligence and Exoskeletons
Published: May 08, 2025 by: GlobeNewsWire
Sentiment: Neutral
MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, May 08, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd.
Read More
First Major U.S. Commercial Health Insurer Approves Purchase of ReWalk 7 Personal Exoskeleton
Published: April 29, 2025 by: GlobeNewsWire
Sentiment: Neutral
Approval signals important progress in U.S. market expansion as major commercial health insurers begin to follow precedent set with Medicare reimbursement for personal exoskeletons established in 2024 Decision to cover device arrives shortly after the launch of the ReWalk 7 Personal Exoskeleton, which was released for sales in the U.S. earlier this month MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, April 29, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd.
Read More
Lifeward Stock Falls Despite FDA Clearance of ReWalk 7 Exoskeleton
Published: March 17, 2025 by: Zacks Investment Research
Sentiment: Neutral
LFWD secures FDA clearance for its ReWalk 7 Exoskeleton, introducing enhanced features to empower individuals with spinal cord injury and expand mobility options.
Read More
FDA Issues Clearance for ReWalk 7 Exoskeleton
Published: March 13, 2025 by: GlobeNewsWire
Sentiment: Neutral
Seventh Generation of Industry-Leading Exoskeleton Includes New and Enhanced Features for Individuals with Spinal Cord Injury Seventh Generation of Industry-Leading Exoskeleton Includes New and Enhanced Features for Individuals with Spinal Cord Injury
Read More
Lifeward Ltd. (LFWD) Q4 2024 Earnings Call Transcript
Published: March 07, 2025 by: Seeking Alpha
Sentiment: Neutral
Lifeward Ltd. (NASDAQ:LFWD ) Q4 2024 Earnings Conference Call March 7, 2025 8:30 AM ET Company Participants Mike Lawless - CFO Larry Jasinski - CEO Almog Adar - VP, Finance Conference Call Participants Yale Jen - Laidlaw & Company Ben Haynor - Lake Street Capital Markets Swayampakula Ramakanth - H.C.
Read More
Lifeward (LFWD) Reports Q4 Loss, Tops Revenue Estimates
Published: March 07, 2025 by: Zacks Investment Research
Sentiment: Negative
Lifeward (LFWD) came out with a quarterly loss of $0.38 per share versus the Zacks Consensus Estimate of a loss of $0.20. This compares to loss of $0.35 per share a year ago.
Read More
About ReWalk Robotics Ltd. (LFWD)
- IPO Date 2014-09-12
- Website https://www.rewalk.com
- Industry Medical - Devices
- CEO Lawrence J. Jasinski BS, MBA
- Employees 80